Q-linea AB (publ) announced that the company's commercial partner Thermo Fisher Scientific is officially launching ASTar for the European market.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.998 SEK | -0.60% | -2.06% | -46.00% |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
Feb. 27 | Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-46.00% | 21.57M | |
-15.34% | 19.18B | |
-46.15% | 2.73B | |
+14.09% | 1.84B | |
-3.39% | 1.61B | |
+23.19% | 1.18B | |
-10.58% | 1B | |
-21.72% | 898M | |
-12.15% | 710M | |
-17.56% | 694M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Thermo Fisher Scientific Officially Launches ASTar for the European Market